ABX advanced biochemical compounds GmbH

It was no surprise that Takeda Pharmaceutical Co. Ltd. was looking to divest Xiidra, which it got access to following the $62bn acquisition of Shire PLC earlier this year, but the amount that Nov

Novartis AG is ramping up in radiopharmaceuticals, buying US cancer specialist Endocyte Inc. for $2.1bn in a deal, building on the acquisition of Advanced Accelerator Accelerator Applications for $

IN VITRO DIAGNOSTICS Financings CareDx Inc. Molecular diagnostics firm CareDx Inc. netted $18.8mm through the follow-on public offering of 4.99mm common shares (including full exercise of the over